Insider Profile
Doughty, Michael James
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Mar 05, 2022
Most Recent Trade
18
Credibility
Score
67%
Hit Rate
+5.0%
Avg 90d Return
+11.9%
Median 90d Return
9
Evaluated Trades
+23.6%
Best Trade
-14.8%
Worst Trade
Hit rate and returns are based on 9 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
—
Hit Rate · 90d
-11.3%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Mar 05, 2022 $MFC
Manulife Financial
— Other Sell 16,280 $26.02 $424K 34
Mar 05, 2022 $MFC
Manulife Financial
— Other Sell 34,188 $26.02 $890K 34
Feb 28, 2022 $MFC
Manulife Financial
— Plan / DRIP Buy 1,175 $25.52 $30K 34
Feb 18, 2022 $MFC
Manulife Financial
— Exercise Sell 21,246 $12.64 $269K 34
Feb 18, 2022 $MFC
Manulife Financial
— Open Market Buy 21,246 $26.97 $573K 34
Feb 18, 2022 $MFC
Manulife Financial
— Exercise Buy 21,246 $12.64 $269K 34
Dec 31, 2021 $MFC
Manulife Financial
— Plan / DRIP Buy 106 — — 34
Dec 31, 2021 $MFC
Manulife Financial
— Plan / DRIP Buy 5,646 — — 34
Dec 31, 2021 $MFC
Manulife Financial
— Comp. Grant Buy 46,521 $25.15 $1.2M 34
Dec 31, 2021 $MFC
Manulife Financial
— Plan / DRIP Buy 2,730 — — 34
Dec 31, 2021 $MFC
Manulife Financial
— Comp. Grant Buy 31,014 $25.15 $780K 34
Dec 31, 2021 $MFC
Manulife Financial
— Expiry Sell 2,911 — — 34
Dec 15, 2020 $MFC
Manulife Financial
— Other Sell 12,774 $23.10 $295K 34
Sep 30, 2020 $MFC
Manulife Financial
— Plan / DRIP Buy 42 — — 34
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.